Effects of body mass index and waist circumference on antihypertensive efficacy in Patients with primary hypertension

Mengyu HU,Yufang LIU,Junxian SONG,Sufang LI,Hong CHEN
DOI: https://doi.org/10.3969/j.issn.1007-5062.2017.03.008
2017-01-01
Abstract:Objective:Investigate the effects of body mass index(BMI)/waist circumference on blood pressure response to antihypertensive drugs in patients with primary hypertension in order to direct the treatment for obesity-related hypertension.Methods:A total of 338 hospitalized patients with primary hypertension in Peking University People's Hospital were recruited.Baseline data,initial blood pressure and antihypertensive drugs were collected and the follow-up was conducted for patients' blood pressure after 2-month of discharge.Patients were stratified into 2 categories according to whether their blood pressure reached the relative targets and BMI/waist circumference were compared after adjusting for the confounding factors using Logistic analysis to reveal their effects on antihypertensive efficacy.Results:The proportion of patients reached the standard target of blood pressure was 66.6%.In all patients,both BMI and waist circumference were independent risk factors affecting antihypertensive efficacy.Referring to the kind of taken drugs,in patients taking only 1 kind of antihypertensive drugs,BMI and waist circumference did not have effects on antihypertensive efficacy;in patients taking 2 or 3 kinds of antihypertensive drugs,both BMI and waist circumference were independent risk factors affecting antihypertensive efficacy.Referring to waist circumference,in patients with normal weight and obesity,BMI and waist circumference did not have effects on antihypertensive efficacy;in patients with overweight,BMI was independent risk factor affecting antihypertensive efficacy,while waist circumference was not;in patients with abdominal obesity,both BMI and waist circumference were independent risk factors affecting antihypertensive efficacy.Conclusion:BMI and waist circumference are independent risk factors affecting antihypertensive efficacy,especially in patients taking more than 1 kind of antihypertensive drugs and in patients with abdominal obesity.
What problem does this paper attempt to address?